There are regulatory and liability hurdles standing in the way of launching a new transgenic product. Despite past successes, and the knowledge gained from failures and near misses, the road to future commercial success in agricultural biotechnology remains fraught with difficulties. US agricultural biotechnology operations will need to maintain perfect divisions between its “green,” “white” and “red” sectors—food and feed, plant-pharmaceutical, and industrial applications.
Agricultural biotechnology; environment, human health; GMO, genetic engineering, pharming; plant based vaccines; medicinals; regulation; liability, patents; stewardship
Attribution-NonCommercial-NoDerivatives 4.0 International